Nothing Special   »   [go: up one dir, main page]

HK1146894A1 - Compositions and methods for treating nail diseases - Google Patents

Compositions and methods for treating nail diseases

Info

Publication number
HK1146894A1
HK1146894A1 HK11100778.5A HK11100778A HK1146894A1 HK 1146894 A1 HK1146894 A1 HK 1146894A1 HK 11100778 A HK11100778 A HK 11100778A HK 1146894 A1 HK1146894 A1 HK 1146894A1
Authority
HK
Hong Kong
Prior art keywords
nail
pharmaceutical composition
composition
alcohol
volatile
Prior art date
Application number
HK11100778.5A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1146894B (en
Inventor
Gareth Winckle
Gregory T. Fieldson
Original Assignee
Dow Pharmaceutical Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40824613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1146894(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dow Pharmaceutical Sciences, Inc. filed Critical Dow Pharmaceutical Sciences, Inc.
Publication of HK1146894A1 publication Critical patent/HK1146894A1/en
Publication of HK1146894B publication Critical patent/HK1146894B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/496Triazoles or their condensed derivatives, e.g. benzotriazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
HK11100778.5A 2008-01-03 2008-12-30 Compositions and methods for treating diseases of the nail HK1146894B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/006,531 US20090175810A1 (en) 2008-01-03 2008-01-03 Compositions and methods for treating diseases of the nail
US12/006531 2008-01-03
PCT/US2008/014107 WO2009085314A1 (en) 2008-01-03 2008-12-30 Compositions and methods for treating diseases of the nail

Publications (2)

Publication Number Publication Date
HK1146894A1 true HK1146894A1 (en) 2011-07-22
HK1146894B HK1146894B (en) 2015-10-30

Family

ID=

Also Published As

Publication number Publication date
MX2010007230A (es) 2010-12-06
ES2532133T3 (es) 2015-03-24
EP2853274B1 (en) 2018-07-04
RU2519664C2 (ru) 2014-06-20
EP2234621B1 (en) 2014-12-24
JP5623913B2 (ja) 2014-11-12
AU2008343795B2 (en) 2013-03-14
BRPI0822162A2 (pt) 2015-06-16
AU2016277570A1 (en) 2017-01-12
AR070083A1 (es) 2010-03-10
WO2009085314A8 (en) 2010-08-26
EP2234621A1 (en) 2010-10-06
CN101909634A (zh) 2010-12-08
JP5872656B2 (ja) 2016-03-01
PL2234621T3 (pl) 2015-05-29
JP2011508774A (ja) 2011-03-17
EP2234621A4 (en) 2013-10-23
US20150374679A1 (en) 2015-12-31
US20180117028A1 (en) 2018-05-03
JP2015038101A (ja) 2015-02-26
CA2706114C (en) 2018-03-27
US10512640B2 (en) 2019-12-24
US20220362231A1 (en) 2022-11-17
CA2706114A1 (en) 2009-07-09
BRPI0822162B8 (pt) 2021-05-25
US20200215048A1 (en) 2020-07-09
KR20100108555A (ko) 2010-10-07
AU2008343795A1 (en) 2009-07-09
AU2016277570B2 (en) 2018-08-02
WO2009085314A1 (en) 2009-07-09
US9566272B2 (en) 2017-02-14
US20090175810A1 (en) 2009-07-09
RU2010131966A (ru) 2012-02-10
US11213519B2 (en) 2022-01-04
AU2013204596A1 (en) 2013-05-09
US11872218B2 (en) 2024-01-16
US9877955B2 (en) 2018-01-30
BRPI0822162B1 (pt) 2019-04-02
US20170165249A1 (en) 2017-06-15
EP2853274A1 (en) 2015-04-01
BRPI0822162A8 (pt) 2015-09-22

Similar Documents

Publication Publication Date Title
US11872218B2 (en) Compositions and methods for treating diseases of the nail
US10828369B2 (en) Compositions and methods for treating diseases of the nail
JP2011500779A (ja) 新規製剤
HK1146894B (en) Compositions and methods for treating diseases of the nail
US20160271121A1 (en) Antifungal combination therapy